1. Home
  2. Companies
  3. BioCryst Pharmaceuticals
  4. Financial Ratios
  5. DSO Ratio
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 9.89 1.12%

Quarterly report 2025-Q3
added 11-04-2025

report update icon

BioCryst Pharmaceuticals DSO Ratio 2011-2026 | BCRX

Annual DSO Ratio BioCryst Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
55.1 35.9 6.91 11.9 311 166 75.9 88.6 121 47.2 255 44.5 63.3 141

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
311 6.91 102

Quarterly DSO Ratio BioCryst Pharmaceuticals

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
52.2 51.5 54.1 - 1.22 2.38 2.89 - 1.97 1.75 6.21 - 1.82 1.35 3.58 - 10.9 13.7 40.1 187 123 262 287 50.9 1.14 K 1.4 K 205 144 269 31.4 119 143 63.7 180 72 89.1 103 167 142 124 51.9 22 67.5 64.5 108 240 78.7 19.4 85.6 235 85.7 102 72.3 98.9 38.8 102 101 142 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.4 K 1.22 134

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
 		37.5 $ 22.57 0.04 % $ 3.74 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		222 - - $ 86.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		48.3 - -24.86 % $ 820 K usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
 		62.9 $ 1.41 -1.4 % $ 363 M usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
Aravive Aravive
ARAV
 		16.8 - -13.39 % $ 1.45 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
 		150 $ 2.56 -3.76 % $ 16.1 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		16.2 K $ 3.85 -1.39 % $ 9.26 B australiaAustralia
Advaxis Advaxis
ADXS
 		88.1 - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		70.9 $ 20.87 2.3 % $ 976 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		103 $ 4.17 -0.24 % $ 446 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 24.57 -0.16 % $ 3.13 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		0.114 - - $ 26.5 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		182 - - $ 3.45 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		45.6 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
 		2.26 K - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 2.93 -4.87 % $ 6.38 B israelIsrael
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		6.83 - - $ 169 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		13.6 - - $ 867 M germanyGermany
Celldex Therapeutics Celldex Therapeutics
CLDX
 		321 $ 33.62 3.73 % $ 2.23 B usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		147 - - $ 401 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
 		15.6 - -6.63 % $ 13.9 M usaUSA